December 15, 2023 Comments Off on New patent for Boehringer Ingelheim drug SYNJARDY XR Posted in: Patent Added Annual Drug Patent Expirations for SYNJARDY+XR Synjardy Xr is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are seven…
The post New patent for Boehringer Ingelheim drug SYNJARDY XR appeared…
December 15, 2023 Comments Off on New patent for Intra-cellular drug CAPLYTA Posted in: Patent Added Annual Drug Patent Expirations for CAPLYTA Caplyta is a drug marketed by Intra-cellular and is included in one NDA. It is available from two suppliers. There are sixteen patents protecting…
The post New patent for Intra-cellular drug CAPLYTA appeared f…